Cargando…
Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer
SIMPLE SUMMARY: The survival of patients diagnosed with ovarian cancer depends largely on the extent of the disease upon diagnosis. When confined to the ovaries, patients’ 10-year survival is more than 70%. This drastically drops to less than 5% when patients are diagnosed with far-advanced disease....
Autores principales: | Walker, Christopher, Nguyen, Tuan-Minh, Jessel, Shlomit, Alvero, Ayesha B., Silasi, Dan-Arin, Rutherford, Thomas, Draghici, Sorin, Mor, Gil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830619/ https://www.ncbi.nlm.nih.gov/pubmed/33477343 http://dx.doi.org/10.3390/cancers13020325 |
Ejemplares similares
-
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2011) -
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
por: Silasi, Dan-Arin, et al.
Publicado: (2007) -
Comment on “Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer” Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer
por: Mor, Gil, et al.
Publicado: (2019) -
Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
por: Craveiro, Vinicius, et al.
Publicado: (2013) -
Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
por: Craveiro, Vinicius, et al.
Publicado: (2013)